Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis reveals key genes and pathways that the ligand AA-14 acts on pituitary

ABSTRACT: Our research is helpful to understand the physiological and pathological level changes caused by the ligand AA-14 acting on the receptor GPR101 on pituitary, to find the mechanism of the signaling pathway downstream of GPR101 under the action of the ligand, and to determine which signaling pathway is mediated by GPR101

ORGANISM(S): Mus musculus

PROVIDER: GSE241719 | GEO | 2023/08/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptome analysis reveals key genes and pathways that the ligand AA-14 acts on pituitary

Project description:Transcriptome analysis reveals key genes and pathways that the ligand AA-14 acts on pituitary

| PRJNA1009395 | ENA

Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism [RNA-Seq]

Project description:X-linked acrogigantism (X-LAG) is the most severe form of pituitary gigantism and is characterized by aggressive growth hormone (GH)-secreting pituitary tumors that occur in early childhood. X-LAG is associated with chromosome Xq26.3 duplications (the X-LAG locus typically includes the VGLL1, CD40LG, ARGHEF6, RBMX, and GPR101 genes) that lead to massive pituitary tumoral expression of GPR101, a novel regulator of GH secretion. In this work, we aimed to unravel the mechanism by which the duplications lead to marked pituitary misexpression of GPR101 alone. Using 4C-seq, we characterized the normal chromatin structure at the X-LAG locus. Using GPR101, RBMX, and VGLL1 viewpoints, we showed that GPR101 is located within a topologically associating domain (TAD) delineated by a tissue-invariant border that separates it from centromeric genes and regulatory sequences. Then, we showed that the duplications in multiple patients led to ectopic interactions that crossed the invariant TAD border, indicating the existence of a similar and consistent mechanism of neo-TAD formation in X-LAG. Rewiring GPR101-enhancer interaction within the new regulatory unit is likely to cause the high levels of aberrant expression of GPR101 in X-LAG pituitary.

2022-02-23 | GSE193113 | GEO

Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism [4C]

2022-02-23 | GSE193112 | GEO

Transcriptome analysis reveals key genes and pathways that the ligand insB:9-23 acts on pancreatic islets

Project description:Our research is helpful to understand the physiological and pathological level changes caused by the ligand insB acting on the receptor Olfr109 on the islets, to find the mechanism of the signaling pathway downstream of Olfr109 under the action of the ligand, and to determine which signaling pathway is mediated by Olfr109

2021-11-30 | GSE189654 | GEO

Project description:aa

| PRJEB29549 | ENA

Macrophages Solvent, AA, LPS, AA+LPS

Project description:Macrophages Solvent, AA, LPS, AA+LPS

| PRJEB47005 | ENA

MDMs Solvent, AA, IL6, AA+IL6

Project description:MDMs Solvent, AA, IL6, AA+IL6

| PRJEB36942 | ENA

Aa aurantiaca

Project description:Aa aurantiaca

| PRJNA1081415 | ENA